Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors
申请人:——
公开号:US20020035137A1
公开(公告)日:2002-03-21
Compounds of formula (I)
1
or therapeutically acceptable salts thereof, are protein tyrosine kinase PTP
1
B inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
acrylamide derivatives with differently substituted indoles at the 3-position as the core scaffold were designed and synthesized. In addition, the actions of these compounds at the enzyme and cellular levels were evaluated. An MTT assay with different kinds of cells was used to assess the cytotoxic activities of compounds 14e and 14n, which displayed potent hIMPDH2 inhibitory activities (IC50 = 4.207
[EN] HETEROARYL INHIBITORS OF PLASMA KALLIKREIN<br/>[FR] INHIBITEURS HÉTÉROARYLE DE LA KALLICRÉINE PLASMATIQUE
申请人:SHIRE HUMAN GENETIC THERAPIES
公开号:WO2022197758A1
公开(公告)日:2022-09-22
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.